MAL2 and serous adenocarcinoma: MAL2 was found to be significantly overexpressed in high-grade serous carcinomas compared with serous borderline tumors [51,52] expression was highest in serous carcinomas relative to other histological subtypes but was not found to be correlated to patient survival [51,52].